Further studies are needed to evaluate the long-term effects of these beverages, as well as their ability to modulate specific biomarkers (e.g., albumin, glucose, cholesterol fractions, B12, iron, C-reactive protein, BDNF, or inflammatory cytokines) in patients with depression, ADHD, or schizophrenia spectrum disorders. This evidence concerns the gene CRP and attention deficit-hyperactivity disorder.